News You Can Use
Funding Source Affects Outcome
Breast cancer clinical trials funded by pharmaceutical companies are more likely to report positive results than are trials not funded by the industry, shows a study from the University of North Carolina at Chapel Hill and the Dana-Farber Cancer Institute in Boston. More research is necessary to figure out the reason for the discrepancy. (Cancer, Feb. 26)
